Disease or disorder under study: Critical ischemia of the lower limbs in diabetic patients without the possibility of revascularization.~Main valuation variable: Proportion of Adverse Events related to treatment.
Phase II national, multicenter, double-blind, randomized, placebo-controlled, phase-3 clinical trial of 3 parallel groups.